BRISTOL MYERS SQUIBB CO Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Bristol Myers Squibb Co quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Bristol Myers Squibb Co Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$993M, a 107% decline year-over-year.
  • Bristol Myers Squibb Co annual Net Cash Provided by (Used in) Financing Activities for 2024 was $5.13B.
  • Bristol Myers Squibb Co annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$9.42B, a 44.5% increase from 2022.
  • Bristol Myers Squibb Co annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$17B, a 4.55% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

BRISTOL MYERS SQUIBB CO Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$993M -$15.6B -107% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-24
Q1 2024 $14.6B +$17.7B Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-24
Q1 2023 -$3.05B +$2.6B +46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q1 2022 -$5.65B +$1.64B +22.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q1 2021 -$7.3B -$6.24B -592% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q1 2020 -$1.05B +$975M +48.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q1 2019 -$2.03B -$807M -66% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 -$1.22B -$209M -20.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-25
Q1 2017 -$1.01B -$63M -6.63% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q1 2016 -$950M -$268M -39.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q1 2015 -$682M +$510M +42.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q1 2014 -$1.19B -$1.15B -2609% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q1 2013 -$44M +$792M +94.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q1 2012 -$836M -$144M -20.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q1 2011 -$692M -$206M -42.4% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q1 2010 -$486M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28

BRISTOL MYERS SQUIBB CO Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.13B +$14.5B Jan 1, 2024 Dec 31, 2024 10-K 2025-02-12
2023 -$9.42B +$7.55B +44.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-12
2022 -$17B -$738M -4.55% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-12
2021 -$16.2B -$15.1B -1310% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-13
2020 -$1.15B -$8.77B -115% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-14
2019 $7.62B +$11.2B Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 -$3.54B +$542M +13.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-10
2017 -$4.08B -$1.42B -53.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 -$2.65B +$971M +26.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 -$3.62B -$1.19B -48.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-13
2014 -$2.44B -$1.37B -128% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-21
2013 -$1.07B +$3.27B +75.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 -$4.33B -$1.68B -63.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-13
2011 -$2.66B +$686M +20.5% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-14
2010 -$3.34B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.